Patent details

EP3079695 Title: GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

Basic Information

Publication number:
EP3079695
PCT Application Number:
US2014069338
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148242456
PCT Publication Number:
WO2015089067
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
French Title of Invention:
INHIBITEURS DE LA GLUCOSYLCÉRAMIDE SYNTHASE
German Title of Invention:
GLUCOSYLCERAMID-SYNTHASE-HEMMER
SPC Number:

Dates

Filing date:
09/12/2014
Grant date:
17/03/2021
EP Publication Date:
19/10/2016
PCT Publication Date:
18/06/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/03/2021
EP B1 Publication Date:
17/03/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/12/2021
Expiration date:
09/12/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/03/2021
 
 

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
RET-LECUELLE, Gwénaëlle
Address:
France (FR)

2

Name:
ORSINI, Cécile
Address:
France (FR)

3

Name:
ITIER, Jean-Michel
Address:
France (FR)

4

Name:
LEONARD, John P.
Address:
United States (US)

5

Name:
DELEUZE, Jean-François
Address:
France (FR)

6

Name:
VIALE, Sandra
Address:
France (FR)

Priority

Priority Number:
201361914842 P
Priority Date:
11/12/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/439; A61P 9/00;

Publication

European Patent Bulletin

Issue number:
202111
Publication date:
17/03/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages